

info@averywell.com

  • Follow
  • Home
  • Our Mission
  • Our Technology
  • Contact Us
  • News & Blogs
  • Home

Manchester start-up set to launch clinical trials for lung cancer detection

by sanhitamehta | Jul 21, 2023 | News&blogs, Uncategorized

Manchester MedTech company Averywell is set to start UK clinical trials on a ground breaking early detection test for lung cancer later this year. Averywell has developed a proprietary technology to detect microRNA biomarkers at the early onset of lung cancer –...

Averywell revolutionizes late-stage lung cancer diagnosis in the UK with a groundbreaking miRNA-based liquid biopsy. Our non-invasive, precise, and cost-effective technology ensures early detection, enabling timely treatment access for smokers and non-smokers.

Contact Information

Email: info@averywell.com

  • Follow
© 2026 Averywell | All Rights Reserved.